MarketsandMarkets offers a new report, "Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools – Global Trends and Forecasts (2011-2016)," which analyzes and studies the major market drivers, restraints, and opportunities in regions such as North America, Europe, Asia, and the rest of the world.
Next generation DNA sequencing is the fastest growing and the most lucrative segment in the genomics space. With estimated double-digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.
Major applications include whole genome sequencing, exome sequencing, targeted re-sequencing, transcriptome sequencing, RNA sequencing, and ChipSEQ. Emerging platforms in this market would be those focusing on nanopore technologies.
The major factors driving the NGS Market is the decrease in the cost of sequencing with increase in the number of applications of sequencing in various fields of science such as cancer research, bio-fuels, marine sciences, live stock research, agricultural, and veterinary research. Thus, there is more demand for the equipment to understand the genome sequencing and utilize it further for human and environmental benefits.
The global NGS market was valued at $842.5 million in the year 2011, growing at a CAGR of 22.7% from 2012 to 2016. North America commanded the largest share of 51.8% of the overall NGS technology market in 2011.